Naicons SRL
Records under this name other than the patents Naicons SRL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 6 of 6 · Back to Naicons SRL
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,975,930 | Lantibiotic derivatives and process for their preparation Lapsed on the fee record Ended May 22, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 22, 2026 | From the USPTO record |
| US 7,655,676 | Use of amide derivative of GE 2270 factor A3 for the treatment of acne Term ended Term ended Oct 22, 2025 · From the USPTO record | Term ended | Term ended Oct 22, 2025 | From the USPTO record |
| US 7,319,088 | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof Term ended Term ended Sep 25, 2024 · From the USPTO record | Term ended | Term ended Sep 25, 2024 | From the USPTO record |
| US 7,307,057 | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof Term ended Ended no later than Jul 12, 2024 · From the USPTO record | Term ended | Ended no later than Jul 12, 2024 | From the USPTO record |
| US 7,351,687 | Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof Term ended Ended no later than Jul 12, 2024 · From the USPTO record | Term ended | Ended no later than Jul 12, 2024 | From the USPTO record |
| US 7,169,890 | Process for the production of ramoplanin-like amide derivatives Term ended Term ended Sep 8, 2023 · From the USPTO record | Term ended | Term ended Sep 8, 2023 | From the USPTO record |